Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin and acute heart failure
IRCT20150617022794N3Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dapagliflozin in Acute Heart Failure (AHF), sponsored by Semnan University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
dapagliflozin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on IRCT20150617022794N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150617022794N3.